Skip to main content

Natural Awakenings Hudson County NJ

Non-Opioid Pain Killer Approved

plugging in the brain

9dreamstudio from Getty Images/CanvaPro

The U.S. Food and Drug Administration (FDA) has approved a new non-opioid pain reliever called suzetrigine to treat moderate to severe short-term pain in adults. Marketed as Journavx by Vertex Pharmaceuticals, the drug works by blocking a specific channel that transmits pain signals to the brain. After the tragedy of tens of thousands of opioid-related deaths, this non-addictive option for use after surgery or for acute pain management is a welcome alternative. Journavx was evaluated in two randomized, double-blind trials, and was found to demonstrate a statistically significant superior reduction in pain compared to a placebo.


Upcoming Events Near You

No Events in the next 21 days.

Get Free News!

Subscribe

* indicates required
NA Hudson Media Kit 2024

 

Advertise With Us!

 

Shertech Media SEO Services

 

Shertech Media Website Creations

 

Natural News
Instagram